Search clinical trials for: Morocco

Total 160 results

CHU Mohammed VI Marrakech

Recruiting

Abdominal Circumference Measure in Caesarian Section (ACirCuS)

Cesarean Section | Anesthesia, Spinal

Morocco
Avicenna Military Hospital

Recruiting

Plethysmographic Perfusion Index and Fluid Responsiveness (PPI-FR)

Fluid Responsiveness

Morocco
Aristotle University Of Thessaloniki

Not yet recruiting

Predictive Factors for Medullary Thyroid Cancer Aggressiveness (MYELO)

Medullary Thyroid Cancer

China, Switzerland, Spain, Greece, United States, Austria, Belgium, Brazil, Bulgaria, Colombia, Croatia, France, India, Iraq, Italy, Jordan, Morocco, Poland, Serbia, Slovakia, Thailand, Turkey, Ukraine, Vietnam
Hassan II University

Not yet recruiting

Continuous Infusion of Norepinephrine vs Phenylephrine During Spinal Anesthesia for Cesarean Section (INPEACE) (INPEACE)

Cesarean Section Complications | Hypotension

Morocco
Mohammed V Souissi University
Ibn Sina University Hospital, Rabat, Morocco

Recruiting

Instrumental Versus Standard Rehabilitation for Knee Osteoarthritis

Knee Osteoarthritis

Morocco
Proton Collaborative Group

Recruiting

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy (COMPRO)

Breast Cancer

United States
Avicenna Military Hospital

Recruiting

Is Mitral Velocity Time-integral a Marker of Preload-responsiveness in Patients With Acute Circulatory Failure?

Preload-responsiveness

Morocco
Moroccan Society of Surgery

Recruiting

Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer (USB22)

Pain, Postoperative | Breast Neoplasms | Pain, Chronic | Post-Mastectomy Chronic Pain Syndrome

Morocco
University of Siena

Recruiting

AutoInflammatory Disease Alliance Registry (AIDA) (AIDA)

Behcet Syndrome | Uveitis | Hereditary Autoinflammatory Diseases | Schnitzler Syndrome | Scleritis | PFAPA Syndrome | Still Disease | Autoinflammatory Syndrome, Unspecified | Vexas Syndrome

Egypt, Spain, Turkey, Italy, Saudi Arabia, Greece, Belgium, United States, Algeria, Brazil, Germany, Ghana, Iran, Islamic Republic of, Lebanon, Morocco, Poland, Portugal, Romania, Taiwan
Hoffmann-La Roche
PPD

Recruiting

A Study To Evaluate Safety And Efficacy Of Ocrelizumab In Comparison With Fingolimod In Children And Adolescents With Relapsing-Remitting Multiple Sclerosis (Operetta 2)

Relapsing-Remitting Multiple Sclerosis

United States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Argentina, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
World Health Organization
University of Bern; University of Wollongong; Fondation Botnar

Recruiting

Empowering Adolescents to Lead Change Using Health Data

Healthy

Ghana, India, Jamaica, Morocco, Switzerland
Moroccan Society of Surgery

Not yet recruiting

Cross-cultural Adaptation and Validation in Moroccan Arabic Dialect "Darija" of the QoR-15 Postoperative Recovery Quality Score"

Recovery of Function

Morocco
Novo Nordisk A/S

Recruiting

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes (PIONEER TEENS)

Diabetes Mellitus, Type 2

United States, Malaysia, United Kingdom, Australia, Netherlands, Portugal, Austria, Israel, India, Greece, Lebanon, Mexico, New Zealand, North Macedonia, Puerto Rico, Romania, Russian Federation, Taiwan, Ukraine, Morocco, Belgium, Czechi...
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Recruiting

Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD (PHYOX7)

End Stage Renal Disease | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1

Germany, Spain, United States, United Kingdom, Italy, United Arab Emirates, Lebanon, Morocco, France, Romania
Moroccan Society of Surgery

Recruiting

C-protein Reactive for the Detection of Anastomotic Leakage After Surgery for Digestive Cancer

Anastomotic Leak | Digestive System Neoplasm | C-Reactive Protein

Morocco
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (O'HAND)

Multiple Sclerosis, Primary Progressive

Canada, United States, Spain, Croatia, Serbia, Portugal, France, Tunisia, Mexico, Poland, Russian Federation, Australia, Belgium, Italy, United Kingdom, Ukraine, Bulgaria, Colombia, Georgia, Germany, Romania, New Zealand, Lebanon, Aus... and more
Manuel Monreal

Recruiting

Computerized Registry of Patients With Venous Thromboembolism (RIETE) (RIETE)

Venous Thromboembolism

United States, France, Spain, Israel, Italy, Czechia, Vietnam, Austria, Switzerland, Latvia, Argentina, Belgium, Brazil, China, Colombia, Ecuador, Egypt, Germany, Greece, Iran, Islamic Republic of, Ireland, Japan, Morocco, North Macedonia and more
Proton Collaborative Group
University of Florida Health

Recruiting

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Pancreatic Cancer

United States
Proton Collaborative Group

Recruiting

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Breast Cancer | Breast Neoplasm | Breast Tumor | Cancer of the Breast

United States
Proton Collaborative Group

Recruiting

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Prostate Cancer

United States
Proton Collaborative Group

Recruiting

Registry Study for Radiation Therapy Outcomes

Neoplasms

United States
Proton Collaborative Group
University of Florida Health

Recruiting

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Prostate Cancer

United States
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis (Beyond ABR)

Severe Hemophilia A | Moderate Hemophilia A

Brazil, Germany, Italy, Spain, United States, Turkey, United Kingdom, Tunisia, Canada, Hungary, Morocco, Serbia
Hoffmann-La Roche

Active, not recruiting

A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (SKYSCRAPER-07)

Esophageal Squamous Cell Carcinoma

United States, France, Spain, Australia, Korea, Republic of, Argentina, Belgium, China, Portugal, Taiwan, Japan, Germany, Poland, Thailand, United Kingdom, Switzerland, Turkey, Russian Federation, Morocco, Greece, Italy, New Zealand, South Africa and more
Pfizer

Withdrawn

A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco

COVID-19 Drug Treatment
Hoffmann-La Roche

Completed

A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) (IMpassion131)

Triple-Negative Breast Cancer

France, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
Mohammed VI University Hospital

Completed

Gap CO2 in Septic Patient to Predict Cardiomyopathy Septic

Cardiac Output, Low | Cardiac Defect | Gap co2

Morocco
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis (CONSONANCE)

Progressive Multiple Sclerosis (PMS)

United States, Canada, Brazil, France, Netherlands, Ireland, Germany, Italy, Poland, Russian Federation, Spain, Colombia, Morocco, Hungary, Denmark, Lebanon, Mexico, Costa Rica, Bosnia and Herzegovina, Czechia, Egypt, Guatemala, Panama and more
University of Minnesota
National Health and Medical Research Council, Australia; Bristol-Myers Squibb; National Institutes of Health Clinical Center (CC) and other collaborators

Completed

Strategic Timing of Antiretroviral Treatment (START)

HIV Infection

Spain, United States, United Kingdom, Ireland, Australia, Argentina, Denmark, Sweden, Israel, Switzerland, Germany, Brazil, Norway, Chile, Thailand, Peru, Portugal, Greece, Luxembourg, Uganda, Austria, Belgium, Czechia, Estonia, Finland, ... and more
Hoffmann-La Roche

Active, not recruiting

A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer (IMpassion132)

Triple Negative Breast Neoplasms

Korea, Republic of, Italy, China, Finland, France, Hungary, Spain, United Kingdom, Argentina, United States, Bosnia and Herzegovina, Brazil, Chile, Germany, Poland, Russian Federation, Peru, Morocco, Mexico, Portugal, Serbia, Turkey, South Africa and more
Avicenna Military Hospital

Completed

Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.

Hospital-acquired Pneumonia | Ventilator Associated Pneumonia | Community-acquired Pneumonia

Morocco
Cardiatis

Completed

Evaluation of Safety and Efficacy of the Bifurcated Multilayer Flow Modulator (BMFM®). (STREAMLINER)

Aortic Aneurysm, Abdominal | Aortic Aneurysm, Thoracoabdominal

Romania, Slovenia, Belgium, Bulgaria, Morocco
Faculty Of Medicine And Pharmacy, Casablanca

Completed

Multiple Disseminated Hydatidosis With Rare Locations

Echinococcus Infections

Morocco
Imara, Inc.

Terminated

A Study of IMR-687 in Subjects With Sickle Cell Disease

Sickle Cell Disease

United States, Oman, Italy, United Kingdom, Lebanon, Greece, Morocco, Tunisia, Ghana, Kenya, Netherlands, Senegal, Uganda
AnaptysBio, Inc.

Active, not recruiting

Long-Term Safety and Efficacy of Imsidolimab (ANB019) in Subjects With Generalized Pustular Psoriasis (GEMINI2)

Generalized Pustular Psoriasis

United States, Australia, France, Georgia, Germany, Korea, Republic of, Malaysia, Morocco, Poland, Romania, Spain, Taiwan, Thailand, Tunisia, Turkey
AnaptysBio, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP (GEMINI1)

Generalized Pustular Psoriasis

United States, Australia, Georgia, Germany, Korea, Republic of, Malaysia, Morocco, Poland, Romania, Spain, Taiwan, Thailand, Tunisia, Turkey, Slovakia
Genzyme, a Sanofi Company

Active, not recruiting

Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis (TERIKIDS)

Multiple Sclerosis

Belgium, United States, Bulgaria, Canada, China, Estonia, France, Greece, Israel, Lebanon, Lithuania, Morocco, Netherlands, Portugal, Russian Federation, Serbia, Spain, Tunisia, Turkey, Ukraine, United Kingdom
Michaël Hofer
Hospices Civils de Lyon; University Hospital Muenster; Versailles Hospital; University... and other collaborators

Enrolling by invitation

Juvenile Inflammatory Rheumatism (JIR) Cohorte (JIR-cohorte)

Arthritis, Juvenile Rheumatoid

France, Belgium, Switzerland, Germany, Morocco
Mohammed VI University Hospital

Completed

Awake Prone Positioning for COVID-19 Acute Hypoxaemic Respiratory Failure

Oxygen Deficiency | Survival, Prosthesis

Morocco
Universitair Ziekenhuis Brussel

Completed

Advance Care Planning Among Older People From Moroccon Origin in Belgium

Advance Care Planning | Ethnic Minorities | Moroccans | Advance Medical Directives | Muslims | Living Will

Belgium
Pfizer

Completed

A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting

Arthritis, Rheumatoid

Morocco
Mohammed VI University Hospital

Completed

Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19

Obesity | COVID-19 Pandemic

Morocco
International Cancer Research Group, United Arab...
Pfizer; AstraZeneca; Genomic Health®, Inc.

Completed

Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant (SAFIA)

Breast Neoplasm Female

United Arab Emirates, Algeria, Egypt, Jordan, Lebanon, Morocco, Saudi Arabia, Tunisia
Pfizer

Terminated

Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy. (OPTIMISE)

Metastatic Renal Cell Carcinoma

Algeria, Morocco, Egypt, Kuwait
Avicenna Military Hospital

Completed

Validation of the Arabic Version of the Postoperative Quality of Recovery Score 15 (Qor-15Ar)

Postoperative Recovery

Morocco
Deepecho
Centre Hospitalier Universitaire Ibn Rochd; Mohammed VI University Hospital; Hassan... and other collaborators

Completed

Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.

Oligohydramnios | Polyhydramnios | Fetal Growth Restriction | Small for Gestational Age Infant

Morocco
International Agency for Research on Cancer
Referral Centre of Reproductive Health, Fez, Morocco; Referral Centre of Reproductive...

Completed

Efficacy and Acceptability of Thermal Ablation in the Treatment of Cervical Neoplasia

Cervical Neoplasm

Morocco
Imara, Inc.

Terminated

A Study of IMR-687 in Subjects With Beta Thalassemia

β Thalassemia

Israel, France, Malaysia, Turkey, Denmark, Georgia, Greece, Italy, Lebanon, Morocco, Netherlands, Tunisia, United Kingdom
Hoffmann-La Roche

Completed

A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) (TAIL)

Carcinoma, Non-Small-Cell Lung

Italy, Netherlands, Argentina, Brazil, China, Denmark, Greece, Panama, Spain, United Arab Emirates, United Kingdom, Mexico, Poland, Peru, Philippines, Costa Rica, Malaysia, Morocco, Latvia, Lebanon, Sweden, Slovenia, Colombia, Guatemala
Universiteit Antwerpen
Artesis Plantijn University College, Antwerp; Université Mohammed Premier,... and other collaborators

Completed

Diabetes Type 2 in the Eastern Region of Morocco

Quality of Life | Diabetes Mellitus, Type 2 | Adherence, Medication | Diet Habit

Morocco

Search clinical trials for: Morocco

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations